INTRODUCTION
The number of patients with end-stage chronic kidney disease (CKD) has dramatically increased, particularly in recent years. Chronic haemodialysis, kidney transplant, and peritoneal dialysis are major treatment methods (Èer-òevskis, 2008) . Special attention has been paid to early stages of CKD, and some studies have shown that their number has already reached up to 10% of the population (Lewey et al., 2011) . According to Centres for Disease Control and Prevention, there are 16.8% of people at age above 20 in whom chronic kidney disease was proven between 1999 and 2004. Chronic kidney disease results in renal function exhaustion when further life of those patients is impossible without renal replacement therapy (RRT) (Èeròevskis, 2008) .
The first haemodialysis in Latvia was applied in the case of acute renal failure patient, it was conducted in 1964 , in Lithuania in 1963 and in Estonia in 1967 . Wider introduction of haemodialysis started in Latvia with the foundation of the Kidney Transplantation Centre in 1973 and the start of operation of the first chronic haemodialysis unit (ßðìî-ëèíñêèé è äð., 1975) . The first kidney transplant surgeries in the Baltic States were made in 1968 in Estonia and 1970 in Lithuania (Kuzminskis et al., 2011) . Then chronic haemodialysis was a preparatory stage for a following kidney transplant surgery, and patients having no contraindications to kidney transplant were subject to hospitalisation.
The aim of this paper was to compare modern chronic haemodialysis with the technologies that existed 40 years ago.
DATA SOURCES
The paper is based on data found in the archives of Latvian Kidney Transplantation Centre. Contemporary data was provided by the Renal Patient Registry, Latvian Association of Nephrology. Data concerning patients was collected from Latvian RRT centres, where electronic record forms on patient incidence, prevalence and lethality at various national RRT centres are summarised every year. The Registry includes data on incident RRT patient age, gender, type of therapy (haemodialysis, peritoneal dialysis, and kidney transplant), and underlying diagnosis, which is obtained from Latvian RRT centres. Similar data are also collected regarding prevalent patients at every RRT centre as of December 31, annually. The data are summarised and published in the Registry website of the European Renal Association -European Dialysis and Transplant Association (ERA-EDTA) and a separate Registry Report every year (Anonymous, 2012) .
Data for the last 2-4 years (2008, 2009, 2010, and 2011) were compared with those from 1973, the time when the first steps were made in practical application of RRT. Some data analyses do not include data for 2011, since data for that year from two RRT centres were incomplete.
Calculations usually were done based on the number of patients per million people. The size of the Latvian population by years of the interest are presented in the (Anonymous, 2011) . Table 3 indicates that differences in patient number by gender only occurred in two years (1973 and 2009 ) when men constituted up to 60% of the total number. Age structure of incident patients greatly differed by years (Table 4 ). In 1973, no patient was older than 45, but relatively more had younger age. For example, six patients had age up to 19 years old (26.66% of the total number of patients in that year). Such a large proportion of young patients in that age group was not observed in subsequent years. Between 2008 and 2010, the largest proportion (33%) of patients was in the age group between 45 and 64, while the proportions of younger patients was between 0.48% (2008) and 2.23% (2010). The number of elder patients increased greatly from 17 to 24%. There was no significant tendency in the age group between 20 and 44 per years (13 to 19%).
PATIENT DIAGNOSIS
Diabetic nephropathy. Diabetic nephropathy is the most frequent disease causing end-stage CKD. According to the US Renal Data System (Anonymous, 2011) , diabetic nephropathy occurs in approximately 44% of all renal pathologies resulting in end-stage CKD, and hypertensive nephropathy occurs in 28% of all cases.
What is situation in Latvia? In 1973, there was no patient commencing RRT who had diabetes mellitus (Table 5 ). In Latvia, as in other countries, the number of diabetes mellitus patients increased in the new millennium, while a decrease of diabetes patients started from 2002 (from 21.2% in 2002 to 14.1% in 2010).
Chronic glomerulonephritis. Chronic glomerulonephritis is still one of the most frequent diagnoses in Latvia (Table 5) . Chronic glomerulonephritis occurred in 62.8% of patients who commenced RRT. The number of glomerulonephritis patients tended to decrease recently in Latvia, as worldwide. In 2002, 28.4% of patients had chronic glomerulonephritis, but in 2010 this proportion decreased by half to 13.4%.
In 1973, chronic pyelonephritis was a common diagnosis in end-stage CKD (22.8%), and its incidence later decreased afterwards. However, a growing tendency of this pathology has again been observed recently (11.2% -13.5% -15.2%, respectively from 2008-2010).
Hypertensive nephropathy. In the United States, hypertensive nephropathy is the second leading pathology in endstage CKD. In Latvia there is also a increasing tendency of the number of patients with this diagnosis. In 1973, no patient had hypertensive nephropathy, but there has been an increase from 4.3% in 2003 to 15.9%, 14.5% and 18.5%, respectively, in subsequent years (Table 5) .
Autosomal dominant polycystic kidney. Autosomal dominant polycystic kidney disease has remained stable (8-10%) over the years, as in other countries (Table 5) . As data from the United States show, 6% of the total number who commenced RRT were PD patients, 92% were chronic haemodialysis patients, and 2% were kidney transplant patients. In Latvia, in some cases pre-emptive kidney transplantation is also made before application of other RRT methods.
The number of kidney transplant surgeries made in Latvia by years is provided in Figure 1 . A total number of prevalent patients under treatment on December 31 of each year is shown in Table 6 . In the USA, 1,811 patients are treated per million people, 2,447 in Taiwan and 1,100 in Belgium. The total number of patients in Latvia has tended to increase yearly and in 2011 has reached 1,020, or 259.3 patients per million people. Similar incidences occur in Rumania (502), Iceland (540), and Brazil (481).
The numbers of patients treated by all RRT methods have tended to increase. 49.5 patients per million people were treated by peritoneal dialysis (7.9% of the total number of patients. According to US data, about 5% of patients are subject to peritoneal dialysis, 30% to kidney transplant, and 65% to chronic haemodialysis as the basic method. In Latvia, approximately equal numbers of patients undergo chronic haemodialysis and kidney transplant. 457 patients are treated by chronic haemodialysis and 482 patients have functioning kidney transplant (205.7 and 217.1 patients per million people, respectively). Data by years are provided in Table 6 .
The main diagnoses in a group of prevalent patients are given in Figure 2 . Obviously, the leading diagnosis is chronic glomerulonephritis (38%) followed by other kidney diseases, which are not specified in more detail (12%), autosomal dominant polycystic kidney disease (11%), diabetic nephropathy and tubule-interstitial kidney damage (10% each), and hypertensive nephropathy (9%).
Comparison of groups of incident and prevalent patients (Figs. 2 and 3) shows that the number of chronic glomerulonephritis patients has increased among prevalent patients, while the number of unidentified etiology chronic renal failure patients has decreased. Other groups of diagnoses do not differ much.
What has contributed to the great increase in number of chronic glomerulonephritis patients? An answer lies in division of diagnoses among kidney transplant patients (Fig. 4) : 45% of all patients were chronic glomerulonephritis patients in 2010. Among diabetic nephropathy patients, 8% are in the group of kidney transplant patients. Diabetes patients are more common among haemodialysis and peritoneal dialysis patients (10%). In 2011, there was a decrease of the number of chronic glomerulonephritis patients in the group of kidney transplant patients and increasing in the group of autosomal dominant polycystic kidney disease patients.
By gender, in 2010 (Table 7) slightly more patients were men (510 or 51.93%) than women. Within age groups also there is no clear difference in number of patients by gender: slightly more men were in the age group, (15.6%), compared to 11.1% for women. More women were in the age group of senior patients above 65 years (16.1%) than were men (14.9%). 
